ViralClear Pharmaceuticals, Inc. — Form D
ViralClear Pharmaceuticals, Inc. of WESTPORT, CT, a company, filed a Form D exempt-offering notice with the SEC on 2019-11-05. The offering totals $20.0M, of which $686K was reported sold. Industry: Other Health Care.
Offering
- Filed: 2019-11-05
- Form: D
- Accession: 0001185185-19-001508
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $20.0M
- Amount sold: $686K
- Remaining: $19.3M
- Investors: 8
- Date of first sale: 2019-10-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-352620
Issuer
- Name: ViralClear Pharmaceuticals, Inc.
- CIK: 0001783807
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 54 WILTON ROAD, WESTPORT, CT, 06880
- Phone: (203) 409-5444
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Natasha Drapeau | Executive Officer | WESTPORT, CT |
| Kenneth Londoner | Executive Officer | New York, NY |
| Steven King | Executive Officer | AGOURA HILLS, CA |
| Samuel Navarro | Director | Pittsburgh, PA |
| Jeffrey O'Donnell | Director | Newtown, PA |
| Dennis Purcell | Director | New York, NY |
| Michael Dougherty | Director | San Antonio, TX |
| Anthony Zook | Director | Charlotte, NC |
| Kenneth Londoner | Director | New York, NY |
| Jerome Zeldis | Director | New York, NY |
| Steve Chaussy | Executive Officer | WESTPORT, CT |
| Nick Spring | Director | WESTPORT, CT |
| Nick Spring | Executive Officer | WESTPORT, CT |
| Natasha Drapeau | Director | WESTPORT, CT |
Other filings by this issuer (3)
More